Am J Transplant, Volume 19, Suppl 3 Archives - Page 157 of 214 - ATC Abstracts

2019 American Transplant Congress
Insulin Resistance as a Surrogate Marker for Post-Transplantation Diabetes Mellitus
D. D. de Lucena, É. B. Rangel, J. R. de Sá, J. O. Medina-Pestana
Department of Medicine, Division of Nephrology, Federal University of São Paulo, São Paulo, Brazil
*Purpose: Post-transplantation diabetes mellitus (PTDM) adversely impact patient and kidney allograft survival. Further knowledge of the risk factors involved in the onset and progression of…
2019 American Transplant Congress
Ganciclovir Based Prophylaxis against Cytomegalovirus Viremia in Pediatric Renal Transplant Patients: A Systematic Review and Meta-Analysis
B. CHATANI¹, W. Glaberson², Z. Nemeth³, L. Tamariz⁴, I. A. Gonzalez¹
¹Pediatric Infectious Disease, University of Miami Miller School of Medicine, Miami, FL, ²Pediatric Nephrology, University of Miami Miller School of Medicine, Miami, FL, ³Health Informatics, University of Miami Miller School of Medicine, Miami, FL, ⁴Population Health and Computation Medicine, University of Miami Miller School of Medicine, Miami, FL
*Purpose: Cytomegalovirus (CMV) disease continues to stand as a significant threat to the longevity of renal transplants in children. More pediatric recipients are CMV negative…
2019 American Transplant Congress
Successful Kidney Transplantation in a Small Child with an Atretic Inferior Vena Cava
J. A. Geha¹, J. D. Geha¹, M. Goss¹, M. L. Kueht¹, R. T. Cotton¹, J. A. Goss¹, A. Rana¹, C. A. O'Mahony¹, P. Srivaths², E. Brewer², N. N. Galvan¹
¹Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, ²Department of Pediatrics, Baylor College of Medicine, Houston, TX
*Purpose: Kidney transplantation is the treatment of choice in pediatric patients with end stage renal disease. This population presents technical challenges particularly in those less…
2019 American Transplant Congress
Cidofovir for BK Nephropathy Rescue Treatment: A Single Center Experience
J. Slatinska¹, E. Honsova², T. Rohal¹, A. Slavcev³, P. Hruba⁴, O. Viklicky¹
¹Nephrology, IKEM, Prague, Czech Republic, ²Pathology, IKEM, Prague, Czech Republic, ³Immunology, IKEM, Prague, Czech Republic, ⁴Transplant Laboratory, IKEM, Prague, Czech Republic
*Purpose: Cidofovir is a potentially nephrotoxic antiviral drug used primarily as a treatment for CMV retinitis however due to its potent antiviral effects has been…
2019 American Transplant Congress
Risk Factors for Graft Loss Vary with Recipient MELD Score in Liver Transplantation
J. A. Steggerda¹, M. B. Bloom¹, T. Todo², T. V. Brennan², N. N. Nissen², A. S. Klein², I. K. Kim²
¹Surgery, Cedars-Sinai Medical Center, Los Angeles, Los Angeles, CA, ²Transplant Surgery, Cedars-Sinai Medical Center, Los Angeles, Los Angeles, CA
*Purpose: Risk factors for allograft loss in liver transplantation have previously been described. Less is known how these vary and interact amongst recipients with different…
2019 American Transplant Congress
Increasing Incidence and Transplantation of Individuals Listed with Alcoholic Liver Disease
E. L. Godfrey¹, A. Rana², J. A. Goss²
¹Department of Student Affairs, Baylor College of Medicine, Houston, TX, ²Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX
*Purpose: Alcoholic liver disease (ALD) has recently become the most common indication for liver transplantation in the US; it is important to characterize changes in…
2019 American Transplant Congress
Organ Procurement Organization Surgeon Improves Utilization of Livers from Pediatric Donors
M. MacConmara¹, J. Reese², T. Anthony², A. Aqul³, S. Hanish¹, P. Vagefi¹, D. Desai¹, C. Hwang¹
¹Surgery (Division of Surgical Transplantation)I, UT Southwestern Medical Center, Dallas, TX, ²Southwest Transplant Alliance, Dallas, TX, ³Childrens Medical Center, Dallas, TX
*Purpose: Pediatric liver transplant centers tend to send their own procurement team for organ assessment and recovery. TXSB organ procurement organization (OPO) hired a full-time…
2019 American Transplant Congress
Caregiving before Thoracic Transplantation–A Qualitative Inquiry
C. C. Kennedy¹, J. Ridgeway¹, E. Stevens¹, J. Kirsch², K. Carroll¹, J. Griffin¹, R. Benzo¹
¹Mayo Clinic, Rochester, MN, ²University of Florida-Gainesville, Gainesville, FL
*Purpose: Although post-transplant caregiver (CG) support is a prerequisite for transplant listing, research shows CG outcomes including stress and social functioning may be worse during…
2019 American Transplant Congress
Comparison of Basiliximab and Alemtuzumab for Lung Transplant Induction
S. Mietz¹, D. Roe², E. Lushin¹, E. Anderson¹, C. Hage²
¹Pharmacy, Indiana University Health, Indianapolis, IN, ²Pulmonary Critical Care, Indiana University Health, Indianapolis, IN
*Purpose: Compare alemtuzumab and basiliximab used for lung transplant in terms of rejection, CLAD, and mortality.*Methods: A retrospective review of lung transplants performed between 2010…
2019 American Transplant Congress
Robotic Pancreas Kidney Transplantation For Type 1 Diabetic Patient With End stage Renal Disease: First Year Experience In Single Institute
S. Lee¹, L. A. Cantrell², A. Agarwal¹, S. K. Rasmussen¹, S. Pelletier¹, K. Brayman¹, J. Oberholzer¹
¹Division of Transplant Surgery, Department of Surgery, University of Virginia Health Sciences Center, Charlottesville, VA, ²Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Virginia Health Sciences Center, Charlottesville, VA
*Purpose: Simultaneous pancreas kidney transplantation for type 1 diabetic patients with end-stage renal disease is a highly successful, but also very invasive surgical procedure. Robotic…